Skip to content

Psilocybin: all studies

Page 66 of 440: studies 651 to 660 of 4,400, newest first. Back to the psilocybin overview

Research

Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa

Journal of Eating Disorders May 26, 2025 Julie Trim, Samantha Shao, Nadav Liam Modlin et al. 14 citations

PT may hold promise not only in the treatment of eating disorders but also trauma-related disorders, including PTSD and dissociative amnesia. Potential mechanisms of psilocybin's facilitation of remembering and processing traumatic material is reviewed.

DOI: 10.1186/s40337-025-01274-2 (opens in new tab) Psilocybin Anorexia nervosa Psychotherapist Hallucinogen

Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice

The International Journal of Neuropsychopharmacology May 25, 2025 Ines Erkizia-Santamaría, Nerea Martínez-Álvarez, Leyre Salinas-Novoa et al. 7 citations

Abstract Background The psychedelic psilocybin has been posited as efficacious for the treatment of depression. However, the potential link between the intensity of acute psychedelic effects and long-term therapeutic outcomes remains undiscovered. Moreover, the impact of classical antidepressant drugs that modulate serotonergic activity on psilocybin’s effects is a clinically relevant concern....

[Psilocybin in the setting of treatment-resistant unipolar depression: A case report].

L'Encephale May 23, 2025 Maroussia Dumenil, Gabriel Cordova, Wissam El-Hage 1 citation

Current antidepressants have shown certain limitations in the treatment of unipolar depression. Their long onset of action, interactions, and side effects are obstacles to achieving lasting remission of this prevalent, often chronic or recurrent, pathology. Faced with this clinical necessity, research efforts have intensified in recent years around psychedelic drugs, with a particular focus on...

Psilocybe cubensis: potencial neuropsicofarmacéutico de la psilocibina y psilocina

Tecnología en Marcha May 20, 2025 Frank Barrientos-Alfaro, Valeria Herrera-Rojas, Michelle Montero-Quesada et al.

Los hongos juegan un papel clave en el mantenimiento de la vida en la tierra, ya que desempeñan múltiples funciones a nivel ecológico. Adicionalmente, son productores de diversos metabolitos secundarios, entre estos, los alcaloides, los cuales en ciertos casos pueden proveer propiedades alucinógenas. Psilocybe cubensis es una especie común de hongos alucinógenos conocida como “hongos mágicos”....

DOI: 10.18845/tm.v37i9.7618 (opens in new tab) Full text (opens in new tab) Alcaloides psicoactivos Hongos Potencial biomédico Fármaco alucinógeno

Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa

Physiology & Behavior May 20, 2025 Kaspar McCoy, Felicia Reed, Kyna‐anne Conn et al. 4 citations

Psilocybin, a serotonergic psychedelic, has emerged as a promising treatment for a range of mental health conditions, including anorexia nervosa. Recent insights from animal models and human imaging studies suggest psilocybin enhances cognitive flexibility and modifies reward processing - two core processes disrupted in anorexia nervosa. Both cognitive flexibility and reward processing are...

Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological and Clinical Approach

Medical & Clinical Case Reports Journal May 19, 2025 Andrés David Turizo Smith, Natalia Jaramillo, Diana Milena Berrío Cuartas

Psilocybin, a psychedelic compound in certain mushrooms, has been used for centuries in spiritual ceremonies and neuropsychiatric therapy.Despite its stigmatization as a Schedule I substance in 1970, research into psilocybin has resurged since the early 2000s, particularly in psychiatry and palliative care.This review examines psilocybins potential to improve the quality of life in palliative...

DOI: 10.51219/mccrj/andres-david-turizo-smith/233 (opens in new tab) Psilocybin Palliative care Intensive care medicine Hallucinogen +2

Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice.

Psychopharmacology May 17, 2025 Shelby A. McGriff, Jacquelin C Hecker, Alexander D. Maitland et al. 12 citations

The head twitch response (HTR) is a spontaneously occurring behavior in mice that is increased in frequency by serotonergic psychedelics. The mouse HTR is often used as a proxy for psychedelic-like drug effects, but limited information is available about sex differences in HTRs evoked by various classes of psychedelics (i.e., phenethylamines, lysergamides, tryptamines). To examine potential sex...

DOI: 10.1007/s00213-025-06795-x (opens in new tab) Full text (opens in new tab) 5-ht2a Head twitch response Mice Psychedelics hallucinogens +6

Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions

Psychedelic Medicine May 16, 2025 Roland R. Griffiths, William A. Richards, Robert L. Jesse et al. 14 citations

Background: Although historical writings, anthropological accounts, and experimental studies document associations between psilocybin use and religion, no prospective experimental study has investigated how the effects of psilocybin are experienced and interpreted by religious clergy. This exploratory study evaluated the overall safety and the acute and enduring effects of psilocybin in clergy....

Tū Wairua: Development of an Indigenous Rongoā Māori approach to healing with psilocybin containing mushrooms

Journal of Psychedelic Studies May 16, 2025 Anna-Leigh Hodge, Anna Forsyth, Tehseen Noorani et al. 6 citations

Abstract Psilocybin, a naturally occurring psychedelic compound found in certain fungi has long been used by Indigenous cultures within ritual and ceremony for healing and spiritual purposes (Spiers et al., 2024). While emerging evidence points to psychedelic agents being novel avenues for the treatment of substance use disorders, the predominantly Western medical models of psychedelic-assisted...

Music and non-music approaches in psilocybin-assisted psychotherapy: The sound of silence

Journal of Psychedelic Studies May 15, 2025 Sara G. Gloeckler, Julien Thibault Lévesque, Alexandre Lehmann et al. 3 citations

Abstract Music is integral to Psilocybin-assisted psychotherapy (PAP), believed to enhance therapeutic outcomes by structuring experiences and facilitating emotional expression. However, the effects of conducting PAP without music are underexplored. This study examines the experiences of two breast cancer patients undergoing psilocybin therapy under Canada's compassionate access program,...